KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Stereotaxis (STXS) Shares Outstanding (2016 - 2025)

Stereotaxis (STXS) has disclosed Shares Outstanding for 16 consecutive years, with $95.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 11.73% to $95.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.3 million through Dec 2025, up 11.73% year-over-year, with the annual reading at $95.3 million for FY2025, 11.73% up from the prior year.
  • Shares Outstanding for Q4 2025 was $95.3 million at Stereotaxis, up from $21121.0 in the prior quarter.
  • The five-year high for Shares Outstanding was $95.3 million in Q4 2025, with the low at $21121.0 in Q3 2025.
  • Average Shares Outstanding over 5 years is $41.2 million, with a median of $40.0 million recorded in 2021.
  • The sharpest move saw Shares Outstanding skyrocketed 331171.7% in 2021, then tumbled 99.97% in 2024.
  • Over 5 years, Shares Outstanding stood at $74.6 million in 2021, then increased by 0.34% to $74.9 million in 2022, then grew by 8.11% to $80.9 million in 2023, then rose by 5.41% to $85.3 million in 2024, then increased by 11.73% to $95.3 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $95.3 million, $91.1 million, and $86.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.